GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » Pretax Margin %

HQY (HealthEquity) Pretax Margin % : 9.61% (As of Jan. 2025)


View and export this data going back to 2014. Start your Free Trial

What is HealthEquity Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. HealthEquity's Pre-Tax Income for the three months ended in Jan. 2025 was $30 Mil. HealthEquity's Revenue for the three months ended in Jan. 2025 was $312 Mil. Therefore, HealthEquity's pretax margin for the quarter that ended in Jan. 2025 was 9.61%.

The historical rank and industry rank for HealthEquity's Pretax Margin % or its related term are showing as below:

HQY' s Pretax Margin % Range Over the Past 10 Years
Min: -8.82   Med: 8.89   Max: 26.4
Current: 9.67


HQY's Pretax Margin % is ranked better than
69.13% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 3.085 vs HQY: 9.67

HealthEquity Pretax Margin % Historical Data

The historical data trend for HealthEquity's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity Pretax Margin % Chart

HealthEquity Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 -8.82 -4.42 7.51 9.67

HealthEquity Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.33 11.56 15.54 2.07 9.61

Competitive Comparison of HealthEquity's Pretax Margin %

For the Health Information Services subindustry, HealthEquity's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity's Pretax Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where HealthEquity's Pretax Margin % falls into.


;
;

HealthEquity Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

HealthEquity's Pretax Margin for the fiscal year that ended in Jan. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Jan. 2025 )/Revenue (A: Jan. 2025 )
=116.034/1199.774
=9.67 %

HealthEquity's Pretax Margin for the quarter that ended in Jan. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2025 )/Revenue (Q: Jan. 2025 )
=29.961/311.817
=9.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthEquity  (NAS:HQY) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


HealthEquity Pretax Margin % Related Terms

Thank you for viewing the detailed overview of HealthEquity's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Executives
Robert W Selander director MASTERCARD INTERNATIONAL, 2000 PURCHASE STREET, PURCHASE NY 10577
Stuart B. Parker director 200 EAST RANDOLPH STREET, SUITE 3300, CHICAGO IL 60601
Elimelech Rosner officer: EVP, Chief Technology Officer 5196 BELMORE COURT, SUWANEE GA 30024
Debra Charlotte Mccowan director 1436 CABRILLO AVENUE, BURLINGAME CA 94010
Frank Corvino director GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Jon Kessler director, officer: President and CEO 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Stephen Neeleman director, officer: Founder and Vice Chairman 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Gayle Furgurson Wellborn director 123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Evelyn S Dilsaver director C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596
Delano Ladd officer: Executive VP, GC & Corp. Secy. 15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks director TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Tyson D. Murdock officer: EVP & CFO 2275 S. 2200 E., SALT LAKE CITY UT 84109
Larry L Trittschuh officer: EVP Chief Security Officer 1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania officer: EVP & CFO 101 WOLF DRIVE, THOROFARE NJ 08086
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184